Mark Neumann

Corporate Officer/Principal at VERADERMICS, INCORPORATED

62 year

Health Technology

Consumer Services

Profile

Mark Neumann is currently Chief Commercial & Strategy Officer at Veradermics, Inc. since 2025 and Chief Commercial Officer & Executive VP at Intra-Cellular Therapies, Inc. since 2018.
Formerly, Mr. Neumann was Vice President-Global Marketing at Amgen, Inc. from 2016 to 2018 and Vice President-Global Commercialization at Bristol Myers Squibb Co. from 2008 to 2014.
Education includes undergraduate studies at Lafayette College.

Mark Neumann active positions

Companies	Position	Start
VERADERMICS, INCORPORATED	Corporate Officer/Principal	01/12/2025

All active positions of Mark Neumann

Former positions of Mark Neumann

Companies	Position	End
INTRA-CELLULAR THERAPIES, INC.	Corporate Officer/Principal	01/04/2025
AMGEN INC.	Sales & Marketing	01/09/2018
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01/05/2014

See the detail of Mark Neumann's experience

Training of Mark Neumann

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Neumann's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Amgen, Inc. Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics	Health Technology
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
Lafayette College Lafayette College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Intra-Cellular Therapies, Inc. Intra-Cellular Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes small molecule drugs to treat neuropsychiatric and neurological disorders	Health Technology
Veradermics, Inc. Veradermics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company for treatment of dermatology and aesthetics problems	Health Technology